Browse the world's most comprehensive database of hedge fund investor letters, sorted by recent quarter. Access primary source research from leading institutional managers.
Browse the world's most comprehensive archive of hedge fund manager letters. Access primary source research from leading institutional managers, sorted by reporting period.
ITUS Capital posted a CY25 return of 2.4%, trailing the Nifty 50 due to an early-year drawdown in pharma, but remains constructive on long-term Indian equities due to superior portfolio-level growth and margins.
Full Quick Take
ITUS Capital posted a CY25 return of 2.4%, trailing the Nifty 50 due to an early-year drawdown in pharma, but remains constructive on long-term Indian equities due to superior portfolio-level growth and margins.
